Application of continuous renal replacement therapy (CRRT) in patients with severe acute pancreatitis: an analytical study

CRRT serves as an independent protective factor against poor outcomes (discharge against medical advice (death within 24 h post-discharge (against medical advice)) /death) in SAP patients, while simultaneously reducing hospitalization duration and vasopressor requirements without increasing financial burden. Early application (within 36 h) demonstrates greater therapeutic benefit. The developed nomogram prediction model, incorporating key prognostic factors, exhibits excellent clinical applicability and provides an objective basis for evaluating treatment timing in patients without strong CRRT indications.